Target intelligence / Profile preview

PHD finger protein 20-like protein 1 (PHF20L1)

Target
PHF20L1
Molecular classification
Chromatin-associated protein, Epigenetic reader, Tudor domain–containing protein, Component of histone modification complexes
01

Overview

PHD finger protein 20-like protein 1 (PHF20L1) is an epigenetic reader protein belonging to a family of Tudor domain–containing proteins that recognize methylated lysine residues on histones and non-histone proteins. PHF20L1 is a component of the nonspecific lethal (NSL) complex and interacts with other chromatin-modifying protein complexes, including the MOF acetyltransferase complex and transcriptional repressor complexes such as PRC2 and NuRD[1][3][5]. It binds monomethylated lysine residues in histones H3 and H4 and in proteins such as DNMT1 and the retinoblastoma tumor suppressor (pRb), influencing gene expression, cell cycle control, and DNA damage response[1][5]. PHF20L1 acts primarily as a transcriptional repressor by reading secondary histone methylation marks (notably H3K27me2) and recruiting repressor complexes, thereby modulating chromatin state and gene activity[3]. Aberrant expression or genetic alterations of PHF20L1 are associated with several cancer types and may affect developmental processes[1][5]. PHF20L1 is currently being explored as a potential "undruggable" epigenetic target, with structural analyses suggesting that its Tudor domain could be inhibited by rationally designed small molecules[2].

Other names
CGI-72FLJ13649FLJ21615MGC64923TDRD20Btudor domain containing 20Btudor domain-containing protein PHF20L1up-regulated in lung cancer 1URLC1
02

Mechanism of action

Not applicable; no known mechanisms of action for drugs as there are currently no approved drugs directly targeting PHF20L1.

03

Biological functions

Methylation-dependent protein bindingTranscriptional regulationNegative regulation of proteasomal degradation of methylated proteinsRegulation of cell cycle progressionMaintenance of stem cell pluripotencyParticipation in DNA damage response
04

Disease associations

Cancer (notably breast and ovarian cancers)Developmental abnormalitiesPotential roles in other diseases through epigenetic misregulation
05

Safety considerations

No specific clinical safety concerns have been reportedTherapeutic targeting of PHF20L1 could pose risks due to its roles in gene expression and chromatin regulation, possibly affecting fundamental cellular functions
06

Biomarkers

Copy number and gene expression changes of PHF20L1 reported as potential biomarkers in several cancers, especially breast and ovarian cancer

Beyond the preview

Go deeper on PHD finger protein 20-like protein 1 (PHF20L1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PHD finger protein 20-like protein 1 (PHF20L1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call